Researchers are looking for new treatments for CLL or SLL. In this trial they are looking at a new drug called nemtabrutinib (MK-1026). It
lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) in late August. Lawsuits around blood cancer drugs are nothing new for
A new BTK-targeting drug compound has shown promise to overcome treatment resistance of chronic lymphocytic leukemia (CLL).
CLL and SLL are forms of slow-growing non-Hodgkin lymphoma that develop from white blood cells known as lymphocytes. 5,6 CLL is one of the most common types of leukemia in adults. 5 In the U.S, CLL accounts for about one-quarter of the new cases of leukemia and there are approximately 18,740 new cases of CLL diagnosed this year. 5,7 SLL is
A Phase 3 trial of a new drug, zanubrutinib, represents a new and more successful treatment for people with Chronic Lymphocytic Leukemia (CLL).
A new drug treatment for chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL) is showing promise during clinical trials.
The new oral drugs for Chronic Lymphocytic Leukemia (CLL) can increase remission rates and extend remission length.
Sorry, in progress, not accepting new patients. This is a Phase 1/2 Venetoclax is an approved drug for the treatment of CLL. Study
by L Fogliatto . CLL: Therapy, excluding Transplantation. Obinutuzumab for CLL Relapsed and Refractory Patients When New Oral Drugs an Not Available. Author
Comments